Events After the Reporting Period

On October 1, 2009, we acquired two dermatology product lines from the U.S. company SkinMedica, Inc., Carlsbad, California, for US$ 63 million (approximately €43 million). These prescription medications, Desonate® and NeoBenz® Micro, are marketed in the United States. The purchase price covers primarily the production rights and brands of the two product lines.

As of November 1, 2009, MaterialScience will revert to the standard collectively agreed work week of 37.5 hours at its German sites. At the beginning of February, MaterialScience had introduced shorter working hours along with a corresponding pay reduction to combat the effects of the economic crisis.